Manufacturer Intelligence · Based on 151,376 FDA 510(k) records · 85 countries

FDA 510(k) Medical Device Manufacturers - Poland

Polish medical device manufacturers ranked by FDA 510(k) submission volume. This is not a curated directory - rankings reflect real submission activity extracted from FDA accessdata.gov records.

  • Compare manufacturers by FDA 510(k) submission activity
  • Identify clearance rates, active panels and years of FDA activity
  • Filter by country or FDA review panel specialty
13
Manufacturers
Poland
Country

Poland FDA 510(k) Overview

13
Manufacturers
19
Submissions
100%
Clearance rate

Leading Poland FDA 510(k) manufacturers include Htl-Strefa S.A, Medinice S.A., Cerkamed Wojciech Pawlowski and 10 others.

Polish medical device manufacturers have submitted 19 FDA 510(k) notifications since 2013, with a 100% clearance rate across 13 manufacturers. Poland's emerging FDA presence reflects the country's growing medical device industry within the European medtech ecosystem, with initial U.S. market entry focused on Class II devices.

Active in FDA 510(k) submissions since 2013. Many Poland manufacturers work with FDA regulatory consultants to support U.S. market entry.

FDA 510(k) Poland Manufacturers

1–13 of 13
# Manufacturer Submissions Cleared Active panels Country
1 7 100%
HO SU
PL
2 1 100%
CV
PL
3
Cerkamed Wojciech Pawlowski
Stalowa Wola, Podkarpacie
1 100%
DE
PL
4 1 100%
OP
PL
5 1 100%
AN
PL
6 1 100%
CV
PL
7 1 100%
PM
PL
8
Chm Sp. Z O.O.
Juchnowiec Koscielny
1 100%
OR
PL
9 1 100%
HO
PL
10 1 100%
GU
PL
11 1 100%
RA
PL
12 1 100%
RA
PL
13 1 100%
AN
PL

About This FDA 510(k) Manufacturer Database

Data Source and Methodology

Rankings are based on the total number of published FDA 510(k) submissions per manufacturer in the 510k Database dataset, derived from FDA 510(k) public files. This is not a curated or paid listing - manufacturer rankings reflect real regulatory activity.

Used by regulatory affairs teams and medtech consultants to benchmark manufacturer activity, identify predicate device candidates, and analyze competitive positioning across FDA review panels.